Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.

INTRODUCTION: The Lambert Eaton myasthenic syndrome (LEMS) is a paraneoplastic disorder associated with raised serum voltage-gated calcium channel (VGCC) antibodies in patients with small cell lung cancer (SCLC). VGCC can also be found in patients with SCLC and cerebellar ataxia. This was a prospec...

Detaylı Bibliyografya
Asıl Yazarlar:	Payne, M, Bradbury, P, Lang, B, Vincent, A, Han, C, Newsom-Davis, J, Talbot, D
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2010

Benzer Materyaller

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Yazar:: Lang, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
Yazar:: Bradbury, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).
Yazar:: Bradbury, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
Yazar:: Maddison, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
Yazar:: Lang, B, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
Yazar:: Squier, M, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
Yazar:: Briggs SEW, ve diğerleri
Baskı/Yayın Bilgisi: (2013-05-01)

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
Yazar:: Titulaer, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
Yazar:: Sumera Bukhari MD, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article
Yazar:: Paulo José Lorenzoni, ve diğerleri

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
Yazar:: Wirtz, P, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
Yazar:: Cruz, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
Yazar:: Palace, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Yazar:: Motomura, M, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Yazar:: Bain, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
Yazar:: Pinto, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Yazar:: Lorenzoni, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
Yazar:: Yutaka Furukawa, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

062 Pembrolizumab induced lambert-eaton myasthenic syndrome
Yazar:: Rob Zielinski, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Lambert Eaton myasthenic syndrome and pregnancies with the development of transient myasthenic syndrome in newborn
Yazar:: N. I. Shcherbakova, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Yazar:: Titulaer, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
Yazar:: Wirtz, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome
Yazar:: Naoya Ishibashi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
Yazar:: Lang, B
Baskı/Yayın Bilgisi: (2007)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Yazar:: Maddison, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Pseudomyopathic Changes in Needle Electromyography in Lambert-Eaton Myasthenic Syndrome
Yazar:: Teppei Komatsu, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome
Yazar:: SUN Qing, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
Yazar:: Lang, B, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer
Yazar:: Kavita Agrawal, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report
Yazar:: Michimi Otani, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
Yazar:: Lehnerer, S, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Electron microscopic study of skeletal muscle in the Lambert–Eaton myasthenic syndrome
Yazar:: L. L. Babakova, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
Yazar:: Simister, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
Yazar:: Wirtz, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
Yazar:: Yuki Nakatani, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Atypical Presentation of Seronegative Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Ataxia
Yazar:: Shalesh Rohatgi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
Yazar:: Pascuzzi RM, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

SOX‐1 antibodies positive Lambert–Eaton myasthenic syndrome with occult small cell lung cancer: A case report
Yazar:: Liming Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Adenocarcinoma pulmonar, dermatomiosite e síndrome miastênica de Lambert-Eaton: uma rara associação Lung adenocarcinoma, dermatomyositis, and Lambert-Eaton myasthenic syndrome: a rare combination
Yazar:: Fernanda Manente Milanez, ve diğerleri
Baskı/Yayın Bilgisi: (2008-05-01)

Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Yazar:: Rozsa, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)